Approval Equities

Pharmaceuticals
Alembic Pharma Secures US FDA Approval for Alcaftadine Ophthalmic Solution Oct 4, 2024
Pharmaceuticals
Cingulate Gears Up for Commercialization as FDA Nods to Marketing Approval Application for CTx-1301 Aug 14, 2024
Companies
Arcutis Biotherapeutics to Discuss ZORYVE® (Roflumilast Cream 0.15%) FDA Approval in Upcoming KOL Event Jul 23, 2024
Pharmaceuticals
Biogen Announces European Approval for Tocilizumab Biosimilar, TOFIDENCE™ Jun 25, 2024
Pharmaceuticals
Ipsen Achieves FDA Accelerated Approval for Iqirvo® as Innovative PPAR Treatment for Primary Biliary Cholangitis Jun 11, 2024
Pharmaceuticals
Cidara Therapeutics Celebrates European Commission Approval for Rezzayo as Stocks Soar Dec 27, 2023